Arcus Biosciences RCUS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's free cash flow?
- Arcus Biosciences (RCUS) reported free cash flow of -$138M in Q1 2026.
- How has Arcus Biosciences's free cash flow changed year-over-year?
- Arcus Biosciences's free cash flow decreased by 3.8% year-over-year, from -$133M to -$138M.
- What is the long-term trend for Arcus Biosciences's free cash flow?
- Over 2 years (2021 to 2025), Arcus Biosciences's free cash flow has grown at a 31.0% compound annual growth rate (CAGR), from -$282M to -$484M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.